Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study
Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study
Prostate Cancer and Prostatic Diseases advance online publication, April 11 2017.
doi:10.1038/pcan.2017.14
Authors: H-J Shih, M-C Kao, P-S Tsai, Y-C Fan & C-J Huang
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: H-J Shih M-C Kao P-S Tsai Y-C Fan C-J Huang Source Type: research